Pharmaceuticals, Biotechnology and Life Sciences
Brenntag, the global market leader in chemicals and ingredients distribution, held a celebration to mark its 150-year anniversary yesterday in Essen, Germany, where the DAX40 company is headquartered.
Over-65s across the UK are set to benefit from potentially life-changing new treatment options for conditions like cancer and cardiovascular disease, thanks to an innovative new clinical trials initiative from healthtech company Cera.
SLEEVER®, a French family-owned group International SME and innovative leader in shrinksleeve label technology, and CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the…
World Food Safety Day is jointly facilitated
by the Food and Agriculture Organization
of the United Nations (FAO) and the World
Health Organization (WHO), and aims to
draw attention and inspire action to help
prevent, detect and manage foodborne
risks, contributing to food security,
human health, economic prosperity,
agriculture, market access, tourism and
sustainable development.
The society is changing rapidly, millennials are now 40 years old people, and it’s OK. The Gen-X folks are already planning retirement days, and the world is left into the hands of – I don’t even know what do we call our children – but they’re children. It looks scary to me. We are still here, and we will inform about pharmaceuticals.
Because we’ve seen a lot of antivax narratives, let’s just give you a brief history of immunization. A Journey Through…
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating 20th anniversary of FDA’s approval of Botox Cosmetic.
The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) 21 consortium have published a joint work plan until 2023. The focus of the plan is to prepare, from a methodological and operational perspective, for the coming into application of the Regulation on Health Technology Assessment (EU) 2021/228 in January 2025 after a 3-year implementation period.
Sanofi has launched its Diversity, Equity & Inclusion (DE&I) Board, the first-of-its-kind in the pharmaceutical industry to feature outside advisors. Sanofi’s DE&I Board will include three of the most influential voices in the DE&I space as Board members appointed for 3 years: organizational psychologist & best-selling author John Amaechi, award-winning social entrepreneur Caroline Casey, and DE&I pioneer and renowned thought-leader Dr. Rohini Anand.
Adults treated with medication for high blood pressure present before or during the first 20 weeks of pregnancy, defined as chronic hypertension in pregnancy, had fewer adverse pregnancy outcomes compared to adults who did not receive antihypertensive treatment, according to a study supported by the National Institutes of Health.